What is the level of liabilities of aTyr Pharma this year?
aTyr Pharma has a debt balance of 30 M USD this year.
aTyr Pharma Liabilities 2024
aTyr Pharma Liabilities
30 M USD
aTyr Pharma Dividend yield
Ticker
LIFE
ISIN
US0021202025
WKN
A2PM86
In 2024, aTyr Pharma's total liabilities amounted to 30 M USD, a 23.44% difference from the 24.3 M USD total liabilities in the previous year.
aTyr Pharma Aktienanalyse
What does aTyr Pharma do?
aTyr Pharma Inc is a biotechnology company based in San Diego, California. Founded in 2005, the company has gained a lot of attention in recent years for its focus on developing drugs based on proteomics, the analysis of proteins. The idea for aTyr came from the realization that there are a variety of proteins that can be used as a basis for developing new drugs. The company has developed a unique proteomics platform that allows for the identification and utilization of previously undiscovered proteins to understand biological processes and develop new drugs for diseases. aTyr specializes in the discovery and development of proteins associated with rare but difficult-to-treat diseases. This includes rare muscle diseases and lung diseases. The company collaborates closely with clinicians and scientists to advance its research and development. aTyr's business model is based on the development of new drugs based on proteomics, with a focus on rare diseases that are often neglected. The goal is to improve the quality of life for patients by developing new and innovative drugs. aTyr has various divisions, including therapeutic proteins and diagnostics. The company has a number of drugs in development targeting different diseases. This includes Resolaris, a protein focused on rare muscle diseases, and ATYR1923, developed for the treatment of lung diseases. Resolaris is a novel protein targeting rare muscle diseases such as FSHD and LGMD. It is currently being tested in clinical trials and has the potential to significantly improve the quality of life for patients with these severe conditions. The company is also developing ATYR1923, a protein for the treatment of lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Overall, aTyr Pharma is an innovative company focused on the development of novel drugs based on proteomics. With its unique proteomics platform, the company has the potential to identify and utilize previously undiscovered proteins to understand biological processes and develop new drugs for diseases. With its various divisions, including therapeutic proteins and diagnostics, the company has the potential to improve the treatment of rare and difficult-to-treat diseases and enhance the lives of patients worldwide. aTyr Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing aTyr Pharma's Liabilities
aTyr Pharma's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating aTyr Pharma's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing aTyr Pharma's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
aTyr Pharma's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in aTyr Pharma’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about aTyr Pharma Stock
What were the liabilities of aTyr Pharma compared to the previous year?
The liabilities of aTyr Pharma have increased by 23.44% increased compared to the previous year.
What are the consequences of high debt for investors of aTyr Pharma?
High liabilities can pose a risk for investors of aTyr Pharma, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in aTyr Pharma?
Low liabilities mean that aTyr Pharma has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of aTyr Pharma affect the company?
An increase in liabilities of aTyr Pharma can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of aTyr Pharma affect the company?
A decrease in the liabilities of aTyr Pharma can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of aTyr Pharma?
Some factors that can influence the liabilities of aTyr Pharma include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of aTyr Pharma so important for investors?
The liabilities of aTyr Pharma are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can aTyr Pharma take to modify the liabilities?
To change its liabilities, aTyr Pharma can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does aTyr Pharma pay?
Over the past 12 months, aTyr Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, aTyr Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of aTyr Pharma?
The current dividend yield of aTyr Pharma is .
When does aTyr Pharma pay dividends?
aTyr Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of aTyr Pharma?
aTyr Pharma paid dividends every year for the past 0 years.
What is the dividend of aTyr Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is aTyr Pharma located?
aTyr Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von aTyr Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of aTyr Pharma from 4/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/25/2024.
When did aTyr Pharma pay the last dividend?
The last dividend was paid out on 4/25/2024.
What was the dividend of aTyr Pharma in the year 2023?
In the year 2023, aTyr Pharma distributed 0 USD as dividends.
In which currency does aTyr Pharma pay out the dividend?
The dividends of aTyr Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The aTyr Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von aTyr Pharma
Our stock analysis for aTyr Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of aTyr Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
